The International Project Team Lead spoke about the results of study endpoints that assessed the potential for next-morning residual effects of lemborexant, which is in development for insomnia.
Margaret Moline, PhD
Advertisement
Articles by Margaret Moline, PhD
Advertisement
Latest Updated Articles
Margaret Moline, PhD: Next-Morning Residual Effects of Lemborexant in InsomniaPublished: May 14th 2019 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Anti-MTBR Tau Antibody Etalanetug Given FDA Fast Track Designation
2
NeurologyLive® Friday 5 — October 24, 2025
3
Incidence and Prevalence of Frontotemporal Dementia Similar to Dementia with Lewy Bodies, Meta-Analysis Shows
4
Smartphone-Based App for Muscular Relaxation Significantly Reduces Migraine-Related Disability in Emergency Room Settings
5
